INTRODUCTION
The activation of basophils, mast cells, and polymorphonuclear (PMN)l and mononuclear leukocytes by immunological and other stimuli releases arachidonic acid, which is converted in part by lipoxygenation to unstable hydroperoxy-eicosatetraenoic acids. Although hydroperoxy-eicosatetraenoic acids are transformed largely to mono-hydroxy-eicosatetraenoic acids (HETE) (1-4), 5(S )-hydroperoxy-eicosatetraenoic acid is the unique source of a family of complex HETE, termed leukotrienes, that contain additional polar substituents and three conjugated double bonds (5). 5(S)-hydroxy-6(R)-glutathionyl -7,9 -trans -11,14 -cis -eicosatetraenoic acid (leukotriene C4) and 5(S)-hydroxy-6(R)-cysteinylglycine -7,9 -trans -11,14 -cis -eicosatetraenoic acid (leukotriene D4) are functionally critical components of the slow-reacting substance of anaphylaxis (6, 7) . 5( S),12(R)-dihydroxy-6,8,10(trans/trans/cis)-14-ciseicosatetraenoic acid (5,12-di-HETE or leukotriene B4) and 5 (S )-hydroxy-6,8,11,14-eicosatetraenoic acid elicit human neutrophil and eosinophil chemotaxis and chemokinesis, enhance the expression of PMN leukocyte C3b receptors, increase the intraleukocyte concentration of guanosine 3':5' cyclic monophosphate, and evoke a modest release of lysosomal enzymes from human neutrophils (3, (8) (9) (10) ,uM calcium ionophore A23187 for 60 min at 37°C (2, 3). The radiolabeled HETE were extracted and purified by sequential silicic acid column chromatography and reverse-phase high-performance liquid chromatography as described (2, 8, 12) , and were identified by cochromatography with purified products that had been characterized previously by gas chromatography-mass spectrometry (2, 3, 12) . Human neutrophil chemotaxis was assessed by a modified Boyden chamber technique as described (3, 9) .
Patient population. Definite and classical rheumatoid arthritis (RA) were defined by the criteria of the American Rheumatism Association and patients were classified as having sero-positive RA (RA+) or sero-negative RA (RA-) according to the results of a standard latex fixation test for rheumatoid factor. Patients with spondyloarthritis (SA) and peripheral joint arthritis had diagnoses of ankylosing spondylitis (n = 3), enteropathic spondylitis (n = 1), psoriatic arthritis (n = 1), and Reiter's disease (n = 5). Patients with a noninflammatory arthropathy such as degenerative or traumatic joint disease served as the control subjects. At the time of collection of the synovial material, three of the patients were taking a total of 75-200 mg of indomethacin/d, and the others were taking aspirin in some form at a total daily dose of 2,400-6,000 mg. Some patients were also receiving hydroxychloroquine, gold, penicillamine, and/or 2.5-15 mg/d of Prednisone, but none had received intraarticular corticosteroids in either knee joint for 3 mo or more before the collection of synovial samples for the present study.
Extraction, purification, and measurement of the HETE in fluid and tissue samples. Synovial fluid was aspirated from knee joints and centrifuged at 2,000 g for 10 min at 4°C to remove cells and particulate material; the supernatant fluid was stored at -70°C until the HETE were extracted. 2-g portions of synovial tissue, which had been obtained at surgery and stored at -20°C, were minced in 2 ml of Hanks' solution at 4°C, homogenized for 3 min (Polytron; Brinkmann Instruments, Inc., Westbury, N. Y.), and sonicated for 2 min (Branson Sonic Power Co., Danbury, Conn.; model 140D, 200 W). After 105 dpm of [3H]-12-L-HETE and 5 x 104 dpm of [3H]-5,12-di-HETE were added to each 2-3-ml sample of synovial fluid and synovial tissue sonicate, duplicate 20-dl aliquots were removed for protein (13) and DNA (14) assays; the samples were titrated to pH 4.0 with 2 M citric acid. Each sample was extracted three times with 4 ml of chloroform:methanol (2:1, vol/vol), the tissue sonicates were extracted three times again with 4 ml of ethyl ether, and the organic phases were pooled and dried under N2.
The HETE were resolved and purified by sequential silicic acid column chromatography and reverse-phase highperformance liquid chromatography on a 4.6 x 250-mm Ultrasphere ODS column (Altex Scientific Inc., Berkeley, Calif.) that was equilibrated and developed isocratically with methanol:water:glacial acetic acid (790:210:0.1, vol/vol) at a flow rate of 1 ml/min as described (2, 8, 12) . The 5,12-di-HETE (leukotriene B,) and 5-HETE were recognized by comparing retention times with those of standards that had been purified and identified previously by gas chromatography-mass spectrometry (2, 3, 5) . Each product was quantitated by optical density at the wavelength of maximum absorption, using previously established extinction coefficients (2, 5) . The radioactivity in portions ofthe 12-L-HETE and 5,12-di-HETE peaks was determined to provide an estimate of recovery. The addition of 5 mg of 5-methyl prednisolone acetate to one of each pair of 1-ml samples of synovial fluid from three patients did not alter the recoveries of 5,12-di-HETE or 5-HETE relative to those of the duplicate sample lacking the corticoid. The total nanograms of 5,12-di-HETE and of 5-HETE per milliliter of synovial fluid or per milligram of DNA in synovial tissue were calculated from the quantities recovered and the percent recovery of radiolabeled 5,12-di-HETE and 12-L-HETE, respectively. The reproducibility of the purification procedure was assessed by analyses of a series of replicate portions of several fluids. In each such series, the range of values was < ± 15% of the mean.
RESULTS
The concentration of 5,12-di-HETE in synovial fluid was significantly higher for patients with RA+ (P < 0.05) and patients with SA (P < 0.05) than for the control subjects with a noninflammatory arthropathy (NIA) or those with RA- (Table I, Fig. 1 ). The difference between the concentrations of 5,12-di-HETE in SA and in the NIA control patients was more significant (P < 0.02) when the six patients with SA and synovial fluid levels of5,12-di-HETE above the normal range were analyzed as a separate subgroup. Although the total white blood cell counts and the percentages of PMN leukocytes were higher in the patients with RA or SA than NIA (Table I) , no significant correlation was found between the white blood cell count and the 5,12-di-HETE concentration in synovial fluid of patients with RA+ (r = 0.13) or SA (r = 0.44), or of all the patients considered as a group (r = 0.14). There was no statistically significant difference between the synovial fluid level of 5-HETE in any ofthe groups [FT of patients and that of the control subjects. In contrast, the 5-HETE content of synovial tissues was elevated significantly in RA+ patients relative to control subjects with NIA (P < 0.05), whereas the 5,12-di-HETE content of the tissues was not increased (Fig. 2) . Similar results were obtained when the contents of HETE were expressed in terms of the wet weight of the tissues or the protein concentration of the tissue sonicates.
To assess the relative contribution of the HETE to the overall neutrophil chemotactic activity in inflammatory synovial fluids, the 5,12-di-HETE and 5-HETE were obtained as a mixture by silicic acid chromatography of extracts of 1-ml portions of synovial fluid from four patients with RA+. After determination ofthe yields of HETE according to recovery of the radioactive tracers, the mixtures of HETE each were resuspended in the appropriate fraction of 1 ml of synovial fluid from a patient with NIA. In dose-response studies using 10-200 /.l, the neutrophil chemotactic activity of unextracted portions of synovial fluid from the RA+ patients reached plateau values that ranged from 30.6 to 51.3 net neutrophils/high-power field at a concentration of 50 ,ul/ml of buffer, whereas 50 ,ul of the synovial fluid from the patient with NIA attracted only 6.9 net neutrophils/high-power field. The increment in neutrophil chemotactic activity in the NIA synovial fluid achieved by the addition of HETE purified from the RA+ synovial fluids permitted an estimation that the HETE accounted for 35-57% of the chemotactic activity in the corresponding unextracted synovial fluids. The effect ofa single intra-articular injection of40 mg of 5-methyl prednisolone acetate was examined in six RA+ patients. Before the injection of corticosteroid, the concentrations of 152±+157 ng (±SD) 5,12-di-HETE/ml and 542+182 ng 5-HETE/ml were similar to those for other RA+ patients (Fig. 1) . 3 d to 2 wk after the intra-articular injection, the concentration of 5,12-di-HETE had been reduced significantly to 67±40 ng/ml (p < 0.05), whereas the concentration of 5-HETE was 526±431 ng/ml and had not been altered by the corticosteroid.
DISCUSSION
That lipoxygenase products of arachidonic acid are capable of eliciting inflammatory cellular infiltrates in vivo was demonstrated initially by the rapid influx of eosinophils and the later accumulation of neutrophils in response to the intraperitoneal instillation of microgram quantities of 12-L-HETE in guinea pigs (15) . The possibility that lipoxygenase products are the predominant stimuli of the cellular component of some inflammatory reactions in vivo was suggested by the capacity of the lipoxygenase inhibitor BW755C to suppress the infiltration of PMN leukocytes evoked in the rat paw by the injection of carrageenin, while the cyclooxygenase inhibitor indomethacin prevented the alterations in vascular permeability, but not the leukocyte response (16) . The present data indicate that the synovial levels of the lipoxygenase-derived PMN leukocyte chemotactic factors 5,12-di-HETE or leukotriene B4 and 5-HETE are elevated in relation to active synovitis and compared with the levels in synovia ofsubjects with noninflammatory arthropathies (Figs. 1 & 2) . Leukotriene B4 is chemotactic for neutrophils and eosinophils in vitro at a concentration as low as 3 ng/ml and evokes a maximal chemotactic response at 30 ng/ml, compared with 1,000 ng/ml for 5-HETE and 10,000-20,000 ng/ml for l1-HETE and 12-HETE (10). Thus, the concentration of both leukotriene B4 and 5-HETE in synovial fluid may be sufficient to contribute to the local inflammatory reaction (Fig. 1) . The reduction in the synovial fluid level of leukotriene B4 that followed the intra-articular injection of a corticosteroid in patients with rheumatoid arthritis is similar to the suppression of cutaneous levels of 12-HETE after topical corticosteroid therapy in psoriasis (17) . The reduction in the synovial fluid leukocyte count and the transformation of the residual population from PMN to mononuclear leukocytes after the intra-articular injection of a corticosteroid (18) thus may be mediated in part by the suppression of the generation of lipoxygenase products of arachidonic acid, which are preferentially chemotactic for PMN leukocytes.
